Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; 1 of the 19 sources its claims cite were checked for support.
Abstract
To determine the plasma epinephrine thresholds for its metabolic and hemodynamic actions and plasma epinephrine metabolic clearance rates, 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 microgram/min were performed in each of six normal human subjects. These 30 infusions resulted in steady-state plasma epinephrine concentrations ranging from 24 to 1,020 pg/ml. Plasma epinephrine thresholds were 50-100 pg/ml for increments in heart rate, 75-125 pg/ml for increments in blood glycerol and systolic blood pressure, 150-200 pg/ml for increments in plasma glucose (the resultant of increments in glucose production and decrements in glucose clearance), blood lactate, blood beta-hydroxybutyrate, and diastolic blood pressure, and greater than 400 pg/ml for early decrements in plasma insulin. Changes in blood alanine, plasma glucagon, plasma growth hormone, and plasma cortisol were not detected. At steady-state plasma epinephrine concentrations of 24-74 pg/ml, values overlapping the basal normal range, the mean (+/-SE) plasma metabolic clearance rate of epinephrine was 52 +/- 4 ml x min-1 x kg-1; this value rose to 89 +/- 6 ml x min-1 x kg-1 (P less than 0.01) at steady-state epinephrine concentrations of 90-1,020 pg/ml. We conclude that in human subjects: (a) the plasma epinephrine thresholds for its hemodynamic and metabolic actions lie within the physiologic range, (b) epinephrine and norepinephrine accelerate their own metabolic clearance, and (c) epinephrine is 10 times more potent than norepinephrine.
Overview
CoChat Summary
TL;DR
In six normal human subjects, graded epinephrine infusions showed that hemodynamic and metabolic thresholds occur within the physiologic plasma epinephrine range. The study also found that epinephrine accelerates its own metabolic clearance and is about 10 times more potent than norepinephrine.
Key findings
- Across 30 infusions, steady-state plasma epinephrine concentrations ranged from 24 to 1,020 pg/ml. Thresholds were 50–100 pg/ml for heart-rate increments; 75–125 pg/ml for systolic blood pressure and blood glycerol increments; 150–200 pg/ml for plasma glucose, glucose production, glucose clearance, blood lactate, blood β-hydroxybutyrate, and diastolic blood pressure changes; and >400 pg/ml for early plasma insulin decrements. No significant changes were detected in blood alanine, plasma glucagon, growth hormone, or cortisol.
- Plasma epinephrine metabolic clearance rate was 52±4 ml·min⁻¹·kg⁻¹ at steady-state epinephrine concentrations of 24–74 pg/ml, overlapping the basal normal range, and rose to 89±6 ml·min⁻¹·kg⁻¹ at 90–1,020 pg/ml (P < 0.01), an approximately 70% increase.
- From earlier norepinephrine data, plasma norepinephrine metabolic clearance rate was 25±4 ml·min⁻¹·kg⁻¹ at 229–345 pg/ml and 39±3 ml·min⁻¹·kg⁻¹ at higher levels (P < 0.02), suggesting catecholamines accelerate their own clearance.
- Epinephrine thresholds for direct metabolic and hemodynamic effects (<200 pg/ml) were about 10% of previously determined norepinephrine thresholds (1,500–2,000 pg/ml), indicating epinephrine is ~10-fold more potent.
Methods
- Six normal subjects (five men, one woman) each received five 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 μg/min after an overnight fast, supine, with infusions separated by at least 1 wk.
- Plasma epinephrine and norepinephrine were measured by a single isotope derivative method; glucose by glucose oxidase; insulin, glucagon, and growth hormone by radioimmunoassay; cortisol by competitive protein binding; lactate, alanine, β-hydroxybutyrate, and glycerol by microfluorometric enzymatic techniques. Glucose kinetics used a primed continuous infusion of [6,6-²H₂]glucose with Steele’s equations for nonsteady-state conditions.
- Plasma epinephrine metabolic clearance rate was calculated as measured infusion rate divided by the difference between steady-state and basal plasma epinephrine. Thresholds were estimated by inspection of semilogarithmic plots, extending regression lines through changed data points to the line of no change, and tended to be confirmed by nonlinear least squares regression.
Limitations
- The paper states that the metabolic clearance calculation assumes basal endogenous epinephrine release continues during infusion; if endogenous release ceases, the calculation overestimates clearance, especially at lower steady-state concentrations. It also states that extremity epinephrine uptake may cause overestimation of epinephrine clearance and underestimation of norepinephrine clearance.
- The paper states that threshold estimates were obtained by inspection and extrapolation of the central linear portion of sigmoidal dose-response curves, providing a maximum estimate; nonlinear least squares regression tended to confirm these values.
- Evident from the text: the sample was small (six normal subjects, five men and one woman), and the study examined only normal human subjects, so findings may not generalize to women, other populations, or pathophysiologic states. The authors also note one discrepancy with earlier studies: they did not observe an increase in plasma glucagon during epinephrine infusions.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 10 Not checked · 36 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As noted earlier, plasma epinephrine concentrations of this magnitude do occur during heavy exercise and absolute hypoglycemia, as well as during a variety of acute illnesses.”
What the sources say
- Not checked — no full text of the sourcecites [27] Galbo, H., J. J. Holst, and N. J. Christensen. 1975. Glucagon and plasma catecholamine responses to graded and prolonged exercise in man. J. Appl. Physiol. 38: 70–76. source
- Partly supportedcites [28] Garber, A. J., P. E. Cryer, J. V. Santiago, M. W. Haymond, A. S. Pagliara, and D. M. Kipnis. 1976. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J. Clin. Invest. 58: 7-15. sourceExperimental — accuracy not yet measured
Our copy supports only the hypoglycemia limb of the claim: RESULTS p. 4 reports mean plasma epinephrine rising from 43±2 pg/ml to maximal levels of 2,200±660 pg/ml (50× basal) during insulin-induced hypoglycemia (plasma glucose 89±3 → 39±2 mg/dl, INTRODUCTION p. 1), i.e. concentrations far above 400 pg/ml in absolute hypoglycemia. The exercise and acute-illness limbs are not in our copy — METHODS p. 2 states subjects were maintained on absolute bed rest, and no passage reports epinephrine during heavy exercise or during acute illness; the DISCUSSION (p. 6) instead closes by saying a role for adrenergic mechanisms in 'more physiologic fluctuations' of plasma glucose 'remains to be established.' Searched: exercise/physical exertion, acute illness/stress, epinephrine >400 pg/ml. (LLM, conf=0.75)
- Not matchedcites [30]
The reference list we hold has no entry [30].
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glucose clearance declined and remained suppressed during the infusion of epinephrine at the higher infusion rates”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glucose utilization did not change”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“but lower for increments in blood glycerol, 75–125 pg/ml”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
In the paper
“As noted previously (25), glucose production rose transiently, returning to near base line by 60 min”
What the sources say
- Not checked — no full text of the sourcecites [25] Rizza, R. A., M. W. Haymond, P. E. Cryer, and J. E. Gerich. 1979. Differential effects of physiologic concentrations of epinephrine on glucose production and disposal in man. Am. J. Physiol. 237: E356–E362. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
32 more claims
Create a free account to see all 47 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“plasma epinephrine concentrations do not commonly achieve the threshold level required to affect basal glucose metabolism (7).”
From Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion (1983) · cites this paper as [7]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a more than eightfold increase in mean plasma epinephrine to a level known to have hyperglycemic effects in man (38).”
From Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man (1984) · cites this paper as [38]
Citations
Cites
Effect of Ischemia on Known Substrates and Cofactors of the Glycolytic Pathway in Brain
Lowry, O. H., Passonneau, J. V., Hasselberger, F. X., & Schulz, D. W. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51740-3 · Cited by 2,221
Cryer, P. E., Haymond, M. W., Santiago, J. V., & Shah, S. D. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609092951101 · Cited by 1,101
Self-citationHormone-fuel interrelationships during fasting.
Cahill, G. F., Herrera, M. G., Morgan, A. P., Soeldner, J. S., Steinke, J., Levy, P. L., Reichard, G. A., & Kipnis, D. M. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105481 · Cited by 1,036
A simplified radiometric assay for plasma norepinephrine and epinephrine
Passon, P. G., & Peuler, J. D. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90517-4 · Cited by 637
A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma
SCHALCH, D. S., & PARKER, M. L. (1964) · Nature · doi:10.1038/2031141a0 · Cited by 635
Measurement of “true” glucose production rates in infancy and childhood with 6,6-dideuteroglucose
Bier, D. M., Leake, R. D., Haymond, M. W., Arnold, K. J., Gruenke, L. D., Sperling, M. A., & Kipnis, D. M. (1977) · Diabetes · doi:10.2337/diab.26.11.1016 · Cited by 444
Self-citationGlucagon and plasma catecholamine responses to graded and prolonged exercise in man
Galbo, H., Holst, J. J., & Christensen, N. J. (1975) · Journal of Applied Physiology · doi:10.1152/jappl.1975.38.1.70 · Cited by 406
Immunoassay of Insulin Using a Two-Antibody System.
Morgan, C. R., & Lazarow, A. (1962) · Experimental Biology and Medicine · doi:10.3181/00379727-110-27411 · Cited by 367
Garber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351
Self-citationDetermination of norepinephrine apparent release rate and clearance in humans
Esler, M., Jackman, G., Bobik, A., Kelleher, D., Jennings, G., Leonard, P., Skews, H., & Korner, P. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90371-0 · Cited by 344
Cited by
Items 301–400 of 577
Cohn, S. M., DeRosa, M., McCarthy, J., Song, J., White, C. E., Louden, C., Ehler, B. R., Michalek, J. E., & Landry, D. W. (2013) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31829eff31 · Cited by 22
“Likewise, 100 pg/mL has been demonstrated previously to be the threshold value for pressor response with epinephrine.(4,5)”
BackgroundThe Effect of Clysed and Topical Epinephrine on Intraoperative Catecholamine Levels
Missavage, A. E., Bush, R. L., Kien, N. D., et al. (1998) · doi:10.1097/00005373-199812000-00018 · Cited by 20
Plasma Catecholamine Levels In Cyclic Antidepressant Overdose
Merigian, K. S., Hedges, J. R., Kaplan, L. A., Roberts, J. R., Stuebing, R. C., Pesce, A. J., & Rashkin, M. C. (1991) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659109038610 · Cited by 20
Stable Isotope Methods for Nutritional Diagnosis and Research
Bier, D. M. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1982.tb05287.x · Cited by 19
Self-citationMetabolic effects of chronic infusions of epinephrine and norepinephrine in rats
Racotta, R., Ramirez-Altamirano, L., & Velasco-Delgado, E. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.5.e518 · Cited by 20
Tal, Y., Ribak, Y., Rubin, L., Talmon, A., Shamriz, O., Hershko, A. Y., Blotnick, S., Bouhajib, M., Krayz, G. T., Abrutzky, C., et al. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.06.044 · Cited by 21
Influence of Duration of Hypoglycemia on the Hormonal Counterregulatory Response in Normal Subjects
Kerr, D. E., Macdonald, I. A., & TATTERSALI, R. B. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-6-1118 · Cited by 24
Adrenal Medullary Responses to Repeated Hemorrhage in the Anesthetized Dog*
Lilly, M. P., Engeland, W. C., & Gann, D. S. (1982) · Endocrinology · doi:10.1210/endo-111-6-1917 · Cited by 18
Favoulet, P., Magnin, G., Guilland, J.-C., Beltramo, J.-L., Osmak, L., Benoît, L., Rat, P., Douvier, S., Duvillard, C., & Chauffert, B. (2001) · European Journal of Surgical Oncology · doi:10.1053/ejso.2000.1028 · Cited by 20
Metabolic effects of vasoactive agents
Träger, K., Radermacher, P., Backer, D. D., Vogt, J., Jakob, S. M., & ENSINGER, H. (2001) · Current Opinion in Anaesthesiology · doi:10.1097/00001503-200104000-00006 · Cited by 20
Transforming growth factor-β in the brain regulates fat metabolism during endurance exercise
Ishikawa, T., Mizunoya, W., Shibakusa, T., Inoue, K., & Fushiki, T. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00039.2006 · Cited by 19
“It is well known that catecholamines act through -adrenoreceptors in adipose tissue and induce lipolysis during endurance exercise (5, 6, 11, 34).”
BackgroundReduced epinephrine clearance and glycemic sensitivity to epinephrine in older individuals
Marker, J. C., Clutter, W. E., & Cryer, P. E. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e770 · Cited by 22
Self-citationThe epinephrine-blood platelet connection with special reference to essential hypertension
Kjeldsen, S. E., Rostrup, M., Gjesdal, K., et al. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90843-7 · Cited by 19
Insulin resistance in alloxan-diabetic dogs: Evidence for reversal following insulin therapy
Caruso, G., Proietto, J., Calenti, A. J., & ALFORD, F. P. (1983) · Diabetologia · doi:10.1007/bf00279943 · Cited by 19
Plasma catecholamines, pH, and blood pressure during cardiac arrest in pigs
Lathers, C. M., Tümer, N., & Schoffstall, J. M. (1989) · Resuscitation · doi:10.1016/0300-9572(89)90113-5 · Cited by 19
Catecholamine Measurement in Behavioral Research
Ziegler, M. G. (1989) · Springer eBooks · doi:10.1007/978-1-4899-0906-0_11 · Cited by 20
IgE and non-IgE-mediated pathways in anaphylaxis
Worm, M., Pažur, K., Morakabati, P., & Redhu, D. (2025) · Seminars in Immunopathology · doi:10.1007/s00281-025-01056-7 · Cited by 28
“Additionally, real-world evidence supports its use in managing refractory anaphylaxis, where patients do not respond to standard treatments [129, 136, 137 ].”
Hepatic and gut clearance of catecholamines in the conscious dog
Chu, C. A., Sindelar, D. K., Neal, D. W., & Cherrington, A. D. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90044-6 · Cited by 19
Effects of dipeptide administration on hypoglycaemic counterregulation in type 1 diabetes
M’Bemba, J., Cynober, L., de Bandt, P. J., Taverna, M. J., Chevalier, A., Bardin, C., Slama, G., & Jl, S. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70052-6 · Cited by 19
“The above criteria have been used by other authors because they correspond to physiologically significant hormone responses to hypoglycaemia [27, 28].”
BackgroundLow plasma concentrations of adrenaline and physiological tremor in man.
Fellows, I. W., Macdonald, I. A., Wharrad, H. J., & Birmingham, A. T. (1986) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.4.396 · Cited by 18
Relationship between plasma and platelet epinephrine concentrations in humans
ROSEN, S. G., Sanfield, J. A., Morrow, L., & Zweifler, A. J. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.3.e334 · Cited by 22
Nutrition delivery, workload and performance in a model-based ICU glycaemic control system
Stewart, K. W., Chase, J. G., Pretty, C. G., & Shaw, G. M. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2018.09.005 · Cited by 17
Burn injury alters beta-adrenergic receptor and second messenger function in rat ventricular muscle
Wang, C., & Martyn, J. A. J. (1996) · Critical Care Medicine · doi:10.1097/00003246-199601000-00020 · Cited by 17
The effects of race on norepinephrine clearance
Ziegler, M. G., Mills, P. J., & Dimsdale, J. E. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90584-x · Cited by 17
Burge, M. R., Sobhy, T. A., Qualls, C. R., & Schade, D. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.7993 · Cited by 17
Woolf, P. D. (1986) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(86)80926-x · Cited by 17
Insulin‐antagonistic effects of counterregulatory hormones: Clinical and mechanistic aspects
Smith, U., & Lager, I. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050604 · Cited by 19
Beta‐adrenoceptor blockade in stress due to oral surgery.
Brisse, B., Tetsch, P., Jacobs, W., et al. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb01950.x · Cited by 17
KIMURA, S., MIURA, Y., ADACHI, M., ADACHA, M., NEZU, M., TORIYABE, S., SUGAWARA, T., ISHIZUKA, Y., NOSHIRO, T., TAKAHASHI, M., et al. (1983) · Japanese Circulation Journal · doi:10.1253/jcj.47.1232 · Cited by 17
Beylot, M., Beaufrère, B., Riou, J. P., Khalfallah, Y., MONEGER, A., Odeon, M., Cohen, R., & Mornex, R. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-5-914 · Cited by 17
Sympathetic Abnormalities in Human Hypertension
de Champlain, J., Cousineau, D., Lapointe, L., Lavallée, M., Nadeau, R. A., & Denis, G. (1981) · Clinical and Experimental Hypertension · doi:10.3109/10641968109033674 · Cited by 13
Counterregulatory responses to postprandial hypoglycemia after Roux-en-Y gastric bypass
Øhrstrøm, C. C., Hansen, D. L., Kielgast, U. L., Bergmann, M., Veedfald, S., Holst, J. J., & Worm, D. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.08.037 · Cited by 18
β-Adrenergic Receptors and Angiotensinogen Gene Expression in Mouse Hepatoma Cells In Vitro
Ming, M., Wu, J., Lachance, S., Delalandre, A., Carrière, S., & Chan, J. S. D. (1995) · Hypertension · doi:10.1161/01.hyp.25.1.105 · Cited by 17
Hatch, C. L., Chernow, B., Terézhalmy, G. T., et al. (1984) · Oral Surgery Oral Medicine Oral Pathology · doi:10.1016/0030-4220(84)90076-8 · Cited by 16
Adams, J. H., Irving, G. A., Koeslag, J. H., Lochner, J. D. V., Sandell, R. C., & Wilkinson, C. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016543 · Cited by 18
Acute non-traumatic pain increases the hepatic amino- to urea-N conversion in normal man
Greisen, J. R., Grøfte, T., Hansen, P. O., Jensen, T. S., & Vilstrup, H. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80344-4 · Cited by 16
Metabolic and Cutaneous Events Associated With Hypoglycemia Detected by Sleep Sentry
Clarke, W. L., Carter, W. R., Moll, M., Cox, D. J., Gonder-Frederick, L. A., & Cryer, P. E. (1988) · Diabetes Care · doi:10.2337/diacare.11.8.630 · Cited by 16
“This is particularly confusing because 13 of 18 subjects had elevations in plasma epinephrine levels above the threshold at which at least some autonomic symptoms associated with hypoglycemia have been reported to occur (14).”
BackgroundSelf-citationCardiovascular sensitivity to epinephrine in the trained and untrained states
Martin, W. H., Coyle, E. F., & Ehsani, A. A. (1984) · The American Journal of Cardiology · doi:10.1016/s0002-9149(84)80091-0 · Cited by 16
Plasma Levels of Catecholamines and Dopamine-β-Hydroxylase
Kopin, I. J. (1989) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-73551-6_6 · Cited by 29
de Marchi, S. F., Szabó, B., & Lazzara, R. (1991) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1991.tb01350.x · Cited by 16
Morady, F., Kou, W. H., Kadish, A. H., et al. (1989) · Circulation · doi:10.1161/01.cir.79.4.783 · Cited by 16
Counterregulatory hormones oscillate during steady-state hypoglycemia
Genter, P. M., Berman, N., Jacob, M., & Ipp, E. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e821 · Cited by 18
“The results of this study may provide an explanation for the apparent discrepancy in the response of EGP to the effects of counterregulatory hormones when these are increased by continuous hypoglycemia vs. the effects of exogenous infusion of the same hormones.”
BackgroundInfluentialThe Dawn Phenomenon: Nocturnal Blood Glucose Homeostasis in Insulin‐dependent Diabetes Mellitus
Perriello, G., Feo, P. D., & Bolli, G. B. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb00934.x · Cited by 16
Venous plasma epinephrine levels and the symptoms of stress.
Cameron, O. G., Gunsher, S., & Hariharan, M. (1990) · Psychosomatic Medicine · doi:10.1097/00006842-199007000-00003 · Cited by 16
“spectively). Pulse pressure was defined as systolic blood pressure minus diastolic blood pressure: it was used because it has been demonstrated previously that the physiological effect of epinephrine on blood pressure is an increase in systolic pressure and a decrease in diastolic pressure (37, 39 , 42-58).”
BackgroundMethodInfluentialImportance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs
Perez, G., Kemmer, F. W., Lickley, H. L. A., & Vranić, M. (1981) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1981.241.4.e328 · Cited by 19
Oxidative mechanisms at rest and during exercise
Ghanassia, É., Brun, J. ‐., Mercier, J. G., & de Mauverger, É. R. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.006 · Cited by 20
“[84] Clutter WE, Bier DM, Shah SD, Cryer PE.”
BackgroundPharmacology of the Cardiovascular System
Sturgill, M. G., Kelly, M., & Notterman, D. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-07307-3.10025-4 · Cited by 18
Effect of beta-adrenergic blockade on hormonal responses during continuous and intermittent exercise
Gullestad, L. L., Dolva, L. Ø., Kjeldsen, S. E., Eide, I. A., & KJEKSHUS, J. K. (1989) · Cardiovascular Drugs and Therapy · doi:10.1007/bf01881530 · Cited by 15
Autonomic Effects on the QT Interval
Ahmed, M. W., Kadish, A. H., & Goldberger, J. J. (1996) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.1996.tb00261.x · Cited by 15
Reflex Responses in Plasma Catecholamines Caused by Static Contraction of Skeletal Muscle.
Matsukawa, K., Sadamoto, T., Tsuchimochi, H., Komine, H., Murata, J., & Shimizu, K. (2001) · The Japanese Journal of Physiology · doi:10.2170/jjphysiol.51.591 · Cited by 15
“2 ng/ml for its hemodynamic and metabolic actions in man [12].”
BackgroundHORMONAL RESPONSES TO CARDIAC SURGERY: EFFECTS OF SUFENTANIL, SOMATOSTATIN AND GANGLION BLOCK
DESBOROUGH, J. P., Hall, G. M., Hart, G. R., et al. (1990) · British Journal of Anaesthesia · doi:10.1093/bja/64.6.688 · Cited by 15
“It has been shown in general surgery that glucose concentrations are mirrored by changes in concentrations of adrenaline and noradrenaline [21], and that blood glucose is sensitive to increases in plasma adrenaline [22].”
BackgroundMetabolic and calorigenic effects of dopexamine in healthy volunteers
Geisser, W., Träger, K., Hahn, A., Georgieff, M., & ENSINGER, H. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00020 · Cited by 15
Adiponectin and Adiponectin Receptors in Human Pheochromocytoma
Isobe, K., Fu, L., Tatsuno, I., Takahashi, H., Nissato, S., Hara, H., YASHIRO, T., Suzukawa, K., Takekoshi, K., Shimano, H., et al. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.no885 · Cited by 14
Pearl, R. G., Maze, M., & Rosenthal, M. H. (1987) · Journal of Cardiothoracic Anesthesia · doi:10.1016/s0888-6296(87)92628-7 · Cited by 14
Plasma Leptin Concentrations in Phenylketonuric Patients
Schulpis, K. H., Papakonstantinou, E. D., & Tzamouranis, J. (2000) · Hormone Research in Paediatrics · doi:10.1159/000023510 · Cited by 14
Vascular Access and Drug Therapy in Pediatric Resuscitation
de Caen, A. R., Reis, A. G., & Bhutta, A. T. (2008) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2008.04.009 · Cited by 14
“However, the a-adrenergic effects predominate when higher doses are used [22,23].”
BackgroundImpact of salbutamol on muscle metabolism assessed by 31 P NMR spectroscopy
Decorte, N., Lamalle, L., Carlier, P. G., et al. (2014) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12312 · Cited by 14
“It has been shown that β2-agonists can induce a stimulation of hepatic glucose production and glucose release (Clutter et al., 1980), a stimulation of glycogenolysis and glycolysis with increased lactate and pyruvate release from tissues such as muscle (Rizza et al., 1980), a stimulation of…”
BackgroundHypokalemia from Beta2-Receptor Stimulation by Epinephrine
(1984) · New England Journal of Medicine · doi:10.1056/nejm198405173102017 · Cited by 14
Sources of human urinary epinephrine
Ziegler, M. G., Aung, M., & Kennedy, B. P. (1997) · Kidney International · doi:10.1038/ki.1997.40 · Cited by 16
Metabolic Clearance and Plasma Appearance Rates of Catecholamines in Preterm and Term Fetal Sheep
Padbury, J. F., Ludlow, J. K., Humme, J. A., et al. (1986) · Pediatric Research · doi:10.1203/00006450-198610000-00020 · Cited by 14
The effect of stress on the pharmacokinetics and pharmacodynamics of glibenclamide in diabetic rats
Elaziz, M. A. A., Al-Dhawailie, A. A., & Tekle, A. (1998) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03192296 · Cited by 14
Somogyi and dawn phenomena: Mechanisms
Feo, P. D., Perriello, G., & Bolli, G. B. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040106 · Cited by 14
Factors affecting the plasma insulin concentration shortly after accidental injury in man.
Frayn, K. N., Maycock, P. F., Little, R., et al. (1987) · Emergency Medicine Journal · doi:10.1136/emj.4.2.91 · Cited by 14
Macdonald, I. A., Bennett, T. M., Gale, E. A. M., Green, H., & Walford, S. (1982) · Clinical Science · doi:10.1042/cs0630301 · Cited by 17
The role of skeletal muscle β‐adrenoreceptors in the regulation of plasma potassium
Elfellah, M. S., & Reid, J. L. (1987) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1987.tb00147.x · Cited by 13
Pinheiro, A. C. M., MARQUES, J. F., Vieira, M. S., et al. (2015) · RGO - Revista Gaúcha de Odontologia · doi:10.1590/1981-863720150001000062962 · Cited by 13
Elayan, H. H., Milic, M. S., Sun, P., Gharaibeh, M. N., & Ziegler, M. G. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9819-1 · Cited by 15
Neural Control of Glucagon Secretion
Palmer, J. P., & Porte, D. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_8 · Cited by 16
Plasma Epinephrine Disturbances in Diabetic Subjects during Standing and after Isometric Exercise*
Gustafson, A. B., & Kalkhoff, R. K. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-4-759 · Cited by 13
HåRkanson, E., Rutberg, H., & Jorfeldt, L. (1986) · Clinical Physiology · doi:10.1111/j.1475-097x.1986.tb00076.x · Cited by 13
Physiological response to postural change during mild hypoglycaemia in patients with IDDM
Robinson, A. M., Parkin, H., Macdonald, I. A., & Tattersall, R. B. (1994) · Diabetologia · doi:10.1007/bf00399798 · Cited by 13
Single doses of catecholamines in the rat: Catecholaminotropic, but not hyperglycemic
Epple, A. W., Heim, K., & Vogel, H. (1988) · Comparative Biochemistry and Physiology Part C Comparative Pharmacology · doi:10.1016/0742-8413(88)90149-1 · Cited by 13
Holck, P., Pørksen, N. K., Nielsen, M. F., Nyholm, B., Bak, J. F., Andreasen, F., Møller, N., & Schmitz, O. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.4.e544 · Cited by 14
Electrophysiologic Mechanisms for the Generation of Arrhythmias with Adrenergic Stimulation
Lazzara, R., & de Marchi, S. F. (1989) · Springer eBooks · doi:10.1007/978-3-642-74317-7_19 · Cited by 13
Lickley, H. L. A., Kemmer, F. W., Wasserman, D. H., & Vranić, M. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_16 · Cited by 14
Fasting energy utilization in the smaller of twins with epinephrine-deficient hypoglycemia
Kerr, D. S., BROOKE, O. G., & Robinson, H. M. (1981) · Metabolism · doi:10.1016/0026-0495(81)90212-2 · Cited by 12
Frequency and Outcomes of Hyperlactatemia After Neurosurgery
Kohli-Seth, R. D., Mukkera, S. R., Leibowitz, A. B., et al. (2011) · ICU Director · doi:10.1177/1944451611424486 · Cited by 12
Role of levosimendan in the management of subarachnoid hemorrhage
Varvarousi, G., Xanthos, T. T., Sarafidou, P., Katsioula, E., Georgiadou, M., Eforakopoulou, M., & Pavlou, H. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.11.024 · Cited by 13
The influence of propranolol on the cardiovascular effects and plasma clearance of epinephrine.
Ichinohe, T., IGARASHI, O., & Kaneko, Y. (1991) · PubMed Central · Cited by 14
Connolly, C. C., Ivy, R., Adkins-Marshall, B. A., Dobbins, R. L., Neal, D. W., Williams, P. E., & Cherrington, A. D. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01212-0 · Cited by 12
Cardiac function and plasma catecholamines during upright exercise in healthy young subjects
Kelbæk, H., Gjørup, T., Christensen, N. J., Vestergaard, B., & GODTFREDSEN, J. (1986) · International Journal of Cardiology · doi:10.1016/0167-5273(86)90004-5 · Cited by 13
Basis of false-positive glucagon tests for pheochromocytoma
Kuchel, O., Harnet, P., Buu, N. T., et al. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.96 · Cited by 12
Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon
Staten, M. A., Matthews, D. E., Cryer, P. E., & Bier, D. M. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.2.e185 · Cited by 12
Self-citationGoldfien, A. (1981) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(81)80014-x · Cited by 12
The adrenal medulla in cardiovascular medicine: an untold story
Esler, M., Jennings, G., Schlaich, M. P., Lambert, G. W., Thompson, J. M., Lambert, É., Guo, L. J., Alvarenga, M. E., Esler, D., Eikelis, N., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002748 · Cited by 12
Dai, X., Liu, Z., Xu, L., Gong, Z., Huang, Q., Dong, M., & Huang, X. (2011) · Autonomic Neuroscience · doi:10.1016/j.autneu.2011.10.006 · Cited by 12
Maish, W. N. (2018) · Neurosurgical Review · doi:10.1007/s10143-018-1039-9 · Cited by 11
α2-Adrenergic Disruption of β Cell BDNF-TrkB Receptor Tyrosine Kinase Signaling
Kalwat, M. A., Huang, Z., Binns, D. D., McGlynn, K., & Cobb, M. H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.576396 · Cited by 11
“4 nM) (Clutter et al., 1980) during infusions of drugs or epinephrine itself.”
BackgroundAutonomic and endocrine participation in opioid peptide-induced hyperglycemia
Appel, N. M., Track, N. S., & Loon, G. R. V. (1987) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(87)90151-2 · Cited by 13
Venous plasma adrenaline response to orthostatic syncope during tilting in healthy men
Tatár, P., Bulas, J., Květňanský, R., et al. (1986) · Clinical Physiology · doi:10.1111/j.1475-097x.1986.tb00627.x · Cited by 11
Кузьмин, А. И., Pogorelov, V. M., Zaretsky, D. V., Os, M., & Чазов, Е. И. (1995) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1995.tb09959.x · Cited by 13
Partial inhibition of nitric oxide synthesis in vivo does not inhibit glucose production in man
Sprangers, F., Jellema, W. T., Lopuhaä, C. E., Endert, E., Ackermans, M. T., LIESHOUT, J. J. V., van der Zee, J. S., Romijn, J. A., & Sauerwein, H. P. (2002) · Metabolism · doi:10.1053/meta.2002.28958 · Cited by 13
Exercise and Protein Metabolism
Evans, W. J. (2015) · World review of nutrition and dietetics · doi:10.1159/000422347 · Cited by 10
HåRkanson, E., Rutberg, H., & Jorfeldt, L. (1986) · Clinical Physiology · doi:10.1111/j.1475-097x.1986.tb00075.x · Cited by 11
Lindner, K. H., Prengel, A. W., Pfenninger, E. G., & Lindner, I. M. (1995) · Circulation · doi:10.1161/01.cir.92.4.1020 · Cited by 11
Frechen, S., Suleiman, A. A., Sigaroudi, A., Wachall, B., & Fuhr, U. (2015) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2015.08.002 · Cited by 13
DISSOCIATION BETWEEN CORTICOTROPHIN AND CATECHOLAMINE RESPONSES TO ISOPRENALINE IN HUMANS
Eisenhofer, G., Goldstein, D. S., Stull, R., Gold, P. W., Keiser, H. R., & Kopin, I. J. (1987) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1987.tb00980.x · Cited by 11
“At peak steady state concentrations of isoprenaline, heart rate approximately doubled, a response in excess of that shown to result from similar increases in plasma adrenaline (Clutter et al. 1980; Freyschuss et al. 1986); thus, the lack of ACTH responses to P-adrenoceptor stimulation in the present study cannot be at…”
BackgroundENSINGER, H., Weichel, T., Lindner, K. H., Prengel, A. W., Grünert, A., & Ahnefeld, F. W. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02333017 · Cited by 12
“The baseline plasma concentrations of noradrenaline and adrenaline and the variance were in the range found in other studies [1, 4, 8-15].”
BackgroundResultPrimary Hyperepinephrinemia in Patients Without Pheochromocytoma
Streeten, D. H. P. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390190160028 · Cited by 11
Hormone-independent activation of EGP during hypoglycemia is absent in type 1 diabetes mellitus
Mevorach, M., Kaplan, J., Chang, C., Rossetti, L., & Shamoon, H. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.3.e421 · Cited by 11
“In a previous report (5), levels of plasma epinephrine that were required to significantly increase EGP averaged two- to threefold the levels in our study.”
BackgroundMethodResult
Metadata
- Authors
- Clutter, W. E., Bier, D. M., Shah, S. D., & Cryer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Bier, D M
- Venue
- Journal of Clinical Investigation
- Published
- 1980-07-01
- Volume
- 66
- Issue
- 1
- Pages
- 94-101
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371510
- OpenAlex
- W2133884882
- Cited by
- 576
- References
- 31
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 9 · 2017: 3 · 2016: 3 · 2015: 9 · 2014: 5 · 2013: 5 · 2012: 5
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- epinephrine, norepinephrine, heart rate, blood pressure, blood glucose, blood lactate, beta-hydroxybutyrate, insulin, hemodynamic effects, metabolic effects, dose-response relationship
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Dose-Response Relationship, Drug, Epinephrine, Female, Glucagon, Heart Rate, Humans, Insulin, Kinetics, Male, Metabolic Clearance Rate, Norepinephrine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.